Medications
Clinical trial of malaria vaccine begins in Africa
The vaccine, RTS,S, developed by GlaxoSmithKline (GSK) Biologicals and PATH Malaria Vaccine Initiative (MVI), is currently in phase III clinical trials and has previously reduced episodes of malaria in infants and young children ...
May 25, 2011
0
0
